The Rheumatoid Arthritis market in North America has experienced significant growth in recent years, driven by various factors such as the increasing incidence of RA, supplemented by a rising geriatric population, rising adoption of innovative therapies, and rising awareness about personalized medicine, etc. North America, particularly the U.S., represents one of the largest markets for Rheumatoid Arthritis globally.

According to the UnivDatos Market Insights analysis, the surge in the incidence of RA cases and the rise in demand for personalized medicine will drive the global scenario of Rheumatoid Arthritis. As per their “Rheumatoid Arthritis Market” report, the global market was valued at USD 27 billion in 2023, growing at a CAGR of about 5% during the forecast period from 2024 - 2032 to reach USD billion by 2032.  

For More Detailed Analysis in PDF Format, Visit- https://univdatos.com/get-a-free-sample-form-php/?product_id=63184

The market encompasses a wide range of applications to improve the RA. Here's a detailed overview:

Driving Factors for the Market in North America:

One major factor propelling the Rheumatoid Arthritis (RA) market in North America is the rising incidence of this chronic condition. For instance, as per the data of CDC, Rheumatoid arthritis (RA) affects approximately 1.3 million adults in the United States. Women are disproportionately affected, being up to three times more likely to develop RA compared to men. The disease commonly manifests between the ages of 30 and 60, though the average onset is in the 60s​.

Along with this, the rising elderly population is also driving the market of Rheumatoid Arthritis. For instance, as per the data of Census.gov, The number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% increase. This age group’s share of the total population is also expected to rise from 17% to 23% by 2050. Further, The United States is experiencing a significant increase in its elderly population. As per the data of CDC< As of 2020, over 54 million Americans were aged 65 or older, a number expected to reach 80 million by 2040. This demographic shift contributes to the rising prevalence of RA, as the likelihood of developing RA increases with age​

In recent years, there has been a notable increase in the incidence and prevalence of RA across North America. This trend is attributed to several factors:

1.     Genetic Predisposition

There is a strong genetic component associated with RA. Individuals with a family history of RA are at higher risk of developing the disease. As awareness and diagnosis improve, more cases with a genetic predisposition are being identified​.

2.     Environmental Factors

Environmental exposures such as pollution, smoking, and occupational hazards have been linked to an increased risk of developing RA. For instance, smoking is a well-known risk factor that can trigger RA in genetically predisposed individuals​.

3.     Improved Diagnostic Techniques

Advances in medical technology and diagnostic methods have made it easier to detect RA early. Enhanced imaging techniques and the availability of more specific biomarkers have led to higher detection rates, contributing to the apparent increase in prevalence​.

4.     Lifestyle Changes

Sedentary lifestyles and obesity are emerging as significant risk factors for RA. Increased body weight can exacerbate inflammation and stress on joints, leading to a higher incidence of RA​.

5.     Hormonal Factors

Hormonal changes, particularly in women, play a role in the onset of RA. Women are more likely to develop RA than men, and fluctuations in hormones during pregnancy, menopause, and other life stages can influence the risk​.

6.     Public Awareness and Education

Increased public awareness and education about RA have led to more people seeking medical advice for symptoms earlier. This has resulted in more diagnoses and a higher reported prevalence​.

Explore the Comprehensive Research Overview - https://univdatos.com/report/rheumatoid-arthritis-market

Conclusion:

Rheumatoid arthritis remains a significant public health issue in the US, affecting millions, particularly among the aging population. Effective management relies on a comprehensive approach, combining pharmacological treatments, lifestyle changes, and supportive therapies. As the population ages, the prevalence of RA is expected to rise, underscoring the need for continued research and innovation in treatment options​.

Contact Us:

UnivDatos Market Insights

Email - [email protected]

Website - https://univdatos.com/